|
1
|
Chin AR and Wang SE: Cancer-derived
extracellular vesicles: The ‘soil conditioner’ in breast cancer
metastasis? Cancer Metastasis Rev. 35:669–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lazcano-Ponce EC, Miquel JF, Munoz N,
Herrero R, Ferrecio C, Wistuba II, de Ruiz Alonso P, Urista Aristi
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Q, Zhang CS and Zhang Y: Molecular
aspects of prostate cancer with neuroendocrine differentiation.
Chin J Cancer Res. 28:122–129. 2016.PubMed/NCBI
|
|
4
|
Sabnis AJ and Bivona TG: HSP70 dependence
in rhabdomyosarcoma: Seed or soil? Cell cycle. 16:147–148. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
von der Heide EK, Neumann M, Vosberg S,
James AR, Schroeder MP, Ortiz-Tanchez J, Isaakidis K, Schlee C,
Luther M, Jöhrens K, et al: Molecular alterations in bone marrow
mesenchymal stromal cells derived from acute myeloid leukemia
patients. Leukemia. 31:1069–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kikuchi Y, Kashima TG, Nishiyama T,
Shimazu K, Morishita Y, Shimazaki M, Kii I, Horie H, Nagai H, Kudo
A and Fukayama M: Periostin is expressed in pericryptal fibroblasts
and cancer-associated fibroblasts in the colon. J Histochem
Cytochem. 56:753–764. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Li F, Gao F, Xing L, Qin P, Liang
X, Zhang J, Qiao X, Lin L, Zhao Q and Du L: Periostin promotes
tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling.
Oncotarget. 7:40148–40159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chun HW and Hong R: Significance of the
hedgehog pathway-associated proteins Gli-1 and Gli-2 and the
epithelial-mesenchymal transition-associated proteins Twist and
E-cadherin in hepatocellular carcinoma. Oncol Lett. 12:1753–1762.
2016.PubMed/NCBI
|
|
9
|
Zeng G, Xun W, Wei K, Yang Y and Shen H:
MicroRNA-27a-3p regulates epithelial to mesenchymal transition via
targeting YAP1 in oral squamous cell carcinoma cells. Oncology
Reports. 36:1475–1482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Horiuchi K, Amizuka N, Takeshita S,
Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF and Kudo A:
Identification and characterization of a novel protein, periostin,
with restricted expression to periosteum and periodontal ligament
and increased expression by transforming growth factor beta. J Bone
Miner Res. 14:1239–1249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Litvin J, Selim AH, Montgomery MO, Lehmann
K, Rico MC, Devlin H, Bednarik DP and Safadi FF: Expression and
function of periostin-isoforms in bone. J Cell Biochem.
92:1044–1061. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kruzynska-Frejtag A, Wang J, Maeda M,
Rogers R, Krug E, Hoffman S, Markwald RR and Conway SJ: Periostin
is expressed within the developing teeth at the sites of
epithelial-mesenchymal interaction. Dev Dyn. 229:857–868. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kühn B, del Monte F, Hajjar RJ, Chang YS,
Lebeche D, Arab S and Keating MT: Periostin induces proliferation
of differentiated cardiomyocytes and promotes cardiac repair. Nat
Med. 13:962–969. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gillan L, Matei D, Fishman DA, Gerbin CS,
Karlan BY and Chang DD: Periostin secreted by epithelial ovarian
carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5)
integrins and promotes cell motility. Cancer Res. 62:5358–5364.
2002.PubMed/NCBI
|
|
15
|
Contié S, Voorzanger-Rousselot N, Litvin
J, Bonnet N, Ferrari S, Clézardin P and Garnero P: Development of a
new ELISA for serum periostin: Evaluation of growth-related changes
and bisphosphonate treatment in mice. Calcif Tissue Int.
87:341–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tanabe H, Takayama I, Nishiyama T,
Shimazaki M, Kii S, Li M, Amizuka N, Katsuba Ki and Kudo A:
Periostin associates with Notch1 precursor to maintain Notch1
expression under a stress condition in mouse cells. PLoS One.
5:e122342010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Isono T, Kim CJ, Ando Y, Sakurai H, Okada
Y and Inoue H: Suppression of cell invasiveness by periostin via
TAB1/TAK1. Int J Oncol. 35:425–432. 2009.PubMed/NCBI
|
|
18
|
Kim CJ, Yoshioka N, Tambe Y, Kushima R,
Okada Y and Inoue H: Periostin is down-regulated in high grade
human bladder cancers and suppresses in vitro cell invasiveness and
in vivo metastasis of cancer cells. Int J Cancer. 117:51–58. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanno A, Satoh K, Masamune A, Hirota M,
Kimura K, Umino J, Hamada S, Satoh A, Egawa S, Motoi F, et al:
Periostin, secreted from stromal cells, has biphasic effect on cell
migration and correlates with the epithelial to mesenchymal
transition of human pancreatic cancer cells. Int J Cancer.
122:2707–2718. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ruan K, Bao S and Ouyang G: The
multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci.
66:2219–2230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morra L and Moch H: Periostin expression
and epithelial-mesenchymal transition in cancer: A review and an
update. Virchows Arch. 459:465–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Coutu DL, Wu JH, Monette A, Rivard GE,
Blostein MD and Galipeau J: Periostin, a member of a novel family
of vitamin K-dependent proteins, is expressed by mesenchymal
stromal cells. J Biol Chem. 283:17991–18001. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishioka R, Itoh S, Gui T, Gai Z, Oikawa
K, Kawai M, Tani M, Yamaue H and Muragaki Y: SNAIL induces
epithelial-to-mesenchymal transition in a human pancreatic cancer
cell line (BxPC3) and promotes distant metastasis and invasiveness
in vivo. Exp Mol Pathol. 89:149–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu
M, Shao R, Anderson RM, Rich JN and Wang XF: Periostin potently
promotes metastatic growth of colon cancer by augmenting cell
survival via the Akt/PKB pathway. Cancer Cell. 5:329–339. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoersch S and Andrade-Navarro MA:
Periostin shows increased evolutionary plasticity in its
alternatively spliced region. BMC Evol Biol. 10:302010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tilman G, Mattiussi M, Brasseur F, van
Baren N and Decottignies A: Human periostin gene expression in
normal tissues, tumors and melanoma: Evidences for periostin
production by both stromal and melanoma cells. Mol Cancer.
6:802007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blanchard C, Mingler MK, McBride M, Putnam
PE, Collins MH, Chang G, Stringer K, Abonia JP, Molkentin JD and
Rothenberg ME: Periostin facilitates eosinophil tissue infiltration
in allergic lung and esophageal responses. Mucosal Immunol.
1:289–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong L, Sun H, Lv X, Yang D, Zhang J and
Shi Y: Expression of periostin in the serum of NSCLC and its
function on proliferation and migration of human lung
adenocarcinoma cell line (A549) in vitro. Mol Biol Rep.
37:2285–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sasaki H, Yu CY, Dai M, Tam C, Loda M,
Auclair D, Chen LB and Elias A: Elevated serum periostin levels in
patients with bone metastases from breast but not lung cancer.
Breast Cancer Res Treat. 77:245–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kudo Y, Ogawa I, Kitajima S, Kitagawa M,
Kawai H, Gaffney PM, Miyauchi M and Takata T: Periostin promotes
invasion and anchorage-independent growth in the metastatic process
of head and neck cancer. Cancer Res. 66:6928–6935. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shimamatsu S, Okamoto T, Haro A, Kitahara
H, Kohno M, Morodomi Y, Tagawa T, Okano S, Oda Y and Maehara Y:
Prognostic significance of expression of the epithelial-mesenchymal
transition-related factor brachyury in intrathoracic lymphatic
spread of non-small cell lung cancer. Ann Surg Oncol. 23 Suppl
5:1012–1020. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kudo Y, Iizuka S, Yoshida M, Nguyen PT,
Siriwardena SB, Tsunematsu T, Ohbayashi M, Ando T, Hatakeyama D,
Shibata T, et al: Periostin directly and indirectly promotes tumor
lymphangiogenesis of head and neck cancer. PloS One. 7:e444882012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang W, Sun QK, He YF, Ma DC, Xie MR, Ji
CS and Hu B: Overexpression of periostin is significantly
correlated to the tumor angiogenesis and poor prognosis in patients
with esophageal squamous cell carcinoma. Int J Clin Exp Pathol.
7:593–601. 2014.PubMed/NCBI
|
|
35
|
Heidari P, Esfahani SA, Turker NS, Wong G,
Wang TC, Rustgi AK and Mahmood U: Imaging of secreted extracellular
periostin, an important marker of invasion in the tumor
microenvironment in esophageal cancer. J Nucl Med. 56:1246–1251.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soltermann A, Tischler V, Arbogast S,
Braun J, Probst-Hensch N, Weder W, Moch H and Kristiansen G:
Prognostic significance of epithelial-mesenchymal and
mesenchymal-epithelial transition protein expression in non-small
cell lung cancer. Clin Cancer Res. 14:7430–7437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y, Zhang G, Li J, Tao Q and Tang W:
The expression analysis of periostin in human breast cancer. J Surg
Res. 160:102–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Puglisi F, Puppin C, Pegolo E, Andreetta
C, Pascoletti G, D'Aurizio F, Pandolfi M, Fasola G, Piga A, Damante
G and Di Loreto C: Expression of periostin in human breast cancer.
J Clin Pathol. 61:494–498. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Contié S, Voorzanger-Rousselot N, Litvin
J, Clézardin P and Garnero P: Increased expression and serum levels
of the stromal cell-secreted protein periostin in breast cancer
bone metastases. Int J Cancer. 128:352–360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F and
Yuan YZ: Circulating levels of periostin may help identify patients
with more aggressive colorectal cancer. Int J Oncol. 34:821–828.
2009.PubMed/NCBI
|
|
41
|
Li Z, Zhang X, Yang Y, Yang S, Dong Z, Du
L, Wang L and Wang C: Periostin expression and its prognostic value
for colorectal cancer. Int J Mol Sci. 16:12108–12118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu X, Chang W, Yuan J, Han X, Tan X, Ding
Y, Luo Y, Cai H, Liu Y, Gao X, et al: Periostin expression in
intra-tumoral stromal cells is prognostic and predictive for
colorectal carcinoma via creating a cancer-supportive niche.
Oncotarget. 7:798–813. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Utispan K, Thuwajit P, Abiko Y, Charngkaew
K, Paupairoj A, Chau-in S and Thuwajit C: Gene expression profiling
of cholangiocarcinoma-derived fibroblast reveals alterations
related to tumor progression and indicates periostin as a poor
prognostic marker. Mol Cancer. 9:132010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lv Y, Wang W, Jia WD, Sun QK, Huang M,
Zhou HC, Xia HH, Liu WB, Chen H, Sun SN and Xu GL: High
preoparative levels of serum periostin are associated with poor
prognosis in patients with hepatocellular carcinoma after
hepatectomy. Eur J Surg Oncol. 39:1129–1135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee YJ, Kim IS, Park SA, Kim Y, Lee JE,
Noh DY, Kim KT, Ryu SH and Suh PG: Periostin-binding DNA aptamer
inhibits breast cancer growth and metastasis. Mol Ther.
21:1004–1013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Choi KU, Yun JS, Lee IH, Heo SC, Shin SH,
Jeon ES, Choi YJ, Suh DS, Yoon MS and Kim JH: Lysophosphatidic
acid-induced expression of periostin in stromal cells: Prognoistic
relevance of periostin expression in epithelial ovarian cancer. Int
J Cancer. 128:332–342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu M, Fejzo MS, Anderson L, Dering J,
Ginther C, Ramos L, Gasson JC, Karlan BY and Slamon DJ: Periostin
promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol.
119:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yan W and Shao R: Transduction of a
mesenchyme-specific gene periostin into 293T cells induces cell
invasive activity through epithelial-mesenchymal transformation. J
Biol Chem. 281:19700–19708. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ouyang G, Liu M, Ruan K, Song G, Mao Y and
Bao S: Upregulated expression of periostin by hypoxia in
non-small-cell lung cancer cells promotes cell survival via the
Akt/PKB pathway. Cancer Lett. 281:213–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hong LZ, Wei XW, Chen JF and Shi Y:
Overexpression of periostin predicts poor prognosis in non-small
cell lung cancer. Oncol Lett. 6:1595–1603. 2013.PubMed/NCBI
|
|
51
|
Tischler V, Fritzsche FR, Wild PJ, Stephan
C, Seifert HH, Riener MO, Hermanns T, Mortezavi A, Gerhardt J,
Schraml P, et al: Periostin is up-regulated in high grade and high
stage prostate cancer. BMC Cancer. 10:2732010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tai IT, Dai M and Chen LB: Periostin
induction in tumor cell line explants and inhibition of in vitro
cell growth by anti-periostin antibodies. Carcinogenesis.
26:908–915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang L, Murota H, Serada S, Fujimoto M,
Kudo A, Naka T and Katayama I: Histamine contributes to tissue
remodeling via periostin expression. J Invest Dermatol.
134:2105–2113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li P, Oparil S, Feng W and Chen YF:
Hypoxia-responsive growth factors upregulate periostin and
osteopontin expression via distinct signaling pathways in rat
pulmonary arterial smooth muscle cells. J Appl Physiol (1985).
97:1549–1558. 2004. View Article : Google Scholar
|
|
55
|
Erkan M, Kleeff J, Gorbachevski A, Reiser
C, Mitkus T, Esposito I, Giese T, Büchler MW, Giese NA and Friess
H: Periostin creates a tumor-supportive microenvironment in the
pancreas by sustaining fibrogenic stellate cell activity.
Gastroenterology. 132:1447–1464. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Baril P, Gangeswaran R, Mahon PC, Caulee
K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T and
Lemoine NR: Periostin promotes invasiveness and resistance of
pancreatic cancer cells to hypoxia-induced cell death: Role of the
beta4 integrin and the PI3k pathway. Oncogene. 26:2082–2094. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Oshima A, Tanabe H, Yan T, Lowe GN,
Glackin CA and Kudo A: A novel mechanism for the regulation of
osteoblast differentiation: Transcription of periostin, a member of
the fasciclin I family, is regulated by the bHLH transcription
factor, twist. J Cell Biochem. 86:792–804. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Takayama G, Arima K, Kanaji T, Toda S,
Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T and Izuhara
K: Periostin: A novel component of subepithelial fibrosis of
bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy
Clin Immunol. 118:98–104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shao R, Bao S, Bai X, Blanchette C,
Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired
expression of periostin by human breast cancers promotes tumor
angiogenesis through up-regulation of vascular endothelial growth
factor receptor 2 expression. Mol Cell Biol. 24:3992–4003. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Michaylira CZ, Wong GS, Miller CG,
Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim
SB, Herlyn M, et al: Periostin, a cell adhesion molecule,
facilitates invasion in the tumor microenvironment and annotates a
novel tumor-invasive signature in esophageal cancer. Cancer Res.
70:5281–5292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kikuchi Y, Kunita A, Iwata C, Komura D,
Nishiyama T, Shimazu K, Takeshita K, Shibahara J, Kii I, Morishita
Y, et al: The niche component periostin is produced by
cancer-associated fibroblasts, supporting growth of gastric cancer
through ERK activation. Am J Pathol. 184:859–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
